BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 14597516)

  • 41. The incidence of rebleeding in traumatic hyphema.
    Witteman GJ; Brubaker SJ; Johnson M; Marks RG
    Ann Ophthalmol; 1985 Sep; 17(9):525-6, 528-9. PubMed ID: 4062157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The treatment of traumatic hyphema with topical epsilon-aminocaproic acid.
    Goldberg MF
    Arch Ophthalmol; 1997 Sep; 115(9):1189-90. PubMed ID: 9298063
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
    Wickham L; Bunce C; Wong D; McGurn D; Charteris DG
    Ophthalmology; 2007 Apr; 114(4):698-704. PubMed ID: 17398320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
    Derakhshan A; Firoozi J; Esmaeili S; Bakhtiari E; Abbaspour M; Abrishami M; Zia MJ
    J Fr Ophtalmol; 2022 Jan; 45(1):9-12. PubMed ID: 34949502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secondary hemorrhage in traumatic hyphema. Predictive factors for selective prophylaxis.
    Fong LP
    Ophthalmology; 1994 Sep; 101(9):1583-8. PubMed ID: 8090460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspirin and secondary bleeding after traumatic hyphema.
    Marcus M; Biedner B; Lifshitz T; Yassur Y
    Ann Ophthalmol; 1988 Apr; 20(4):157-8. PubMed ID: 3288070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model.
    Allingham RR; Crouch ER; Williams PB; Catlin JC; Loewy DM; Jacobson J
    Arch Ophthalmol; 1988 Oct; 106(10):1436-8. PubMed ID: 3178555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analysis of systemic anti-fibrinolytics in traumatic hyphaema.
    Aylward GW; Dunlop IS; Little BC
    Eye (Lond); 1994; 8 ( Pt 4)():440-2. PubMed ID: 7821469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial.
    Bolt P; Barnett P; Babl FE; Sharwood LN
    Arch Dis Child; 2008 Jan; 93(1):40-4. PubMed ID: 18156478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.